Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Portfolio Pulse from Avi Kapoor
U.S. stock futures are down, with Dow Jones futures dropping about 100 points. Hewlett Packard Enterprise (HPE) shares fell 8.5% in pre-market trading amid reports of a potential acquisition of Juniper Networks (JNPR) for approximately $13 billion. Other stocks experiencing pre-market losses include Grifols (GRFS), CyberArk Software (CYBR), Summit Therapeutics (SMMT), Nkarta (NKTX), Hologic (HOLX), Microchip Technology (MCHP), Prothena Corporation (PRTA), and Heron Therapeutics (HRTX).
January 09, 2024 | 11:36 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
CyberArk Software shares fell 6.5% to $203.93 in pre-market trading ahead of its Q4 and year-end financial results announcement on Feb. 8, 2024.
The decline in CYBR shares may be due to investor caution ahead of the financial results announcement, which can bring volatility.
CONFIDENCE 70
IMPORTANCE 75
RELEVANCE 70
NEGATIVE IMPACT
Grifols shares plummeted 46.3% to $5.98 in pre-market trading, but the article does not specify the reason.
The significant drop in GRFS shares suggests a negative event or outlook, but without specific details, the impact analysis is less certain.
CONFIDENCE 60
IMPORTANCE 80
RELEVANCE 70
NEGATIVE IMPACT
Hologic shares declined 5% to $67.76 in pre-market trading after announcing preliminary revenue results for Q1, expecting revenue of $1.013 billion.
The drop in HOLX shares indicates that the preliminary revenue results may have not met investor expectations, leading to a negative short-term impact.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 80
NEGATIVE IMPACT
HPE shares dropped 8.5% in pre-market trading due to reports of its potential acquisition of Juniper Networks for around $13 billion.
The pre-market drop in HPE's stock price is likely due to concerns over the cost and integration challenges of the potential acquisition of JNPR.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Heron Therapeutics shares declined 3.8% to $2.01 in pre-market trading after an 18% rise on Monday due to a five-year distribution partnership announcement with CrossLink Life Sciences.
The pre-market decline could be a profit-taking response following the previous day's positive news about the distribution partnership.
CONFIDENCE 65
IMPORTANCE 60
RELEVANCE 60
NEGATIVE IMPACT
Microchip Technology shares declined 4.3% to $81.98 in pre-market trading after the company projected a roughly 22% sequential decline in Q3 revenue, worse than prior guidance.
The negative revision of Microchip Technology's revenue forecast is likely to concern investors, leading to a decrease in stock price.
CONFIDENCE 75
IMPORTANCE 85
RELEVANCE 80
NEGATIVE IMPACT
Nkarta shares declined 5.4% to $10.15 in pre-market trading after a 77% surge on Monday due to an updated corporate presentation with business and strategic updates.
The pre-market drop may be a natural pullback after the previous day's significant rally, as the market processes the updates.
CONFIDENCE 65
IMPORTANCE 65
RELEVANCE 60
NEGATIVE IMPACT
Prothena shares fell 4.2% to $33.79 in pre-market trading, continuing a decline after a 13% drop on Monday following a business update on portfolio programs.
The ongoing decline in Prothena's stock price suggests that the business update may have been received negatively by the market.
CONFIDENCE 65
IMPORTANCE 65
RELEVANCE 60
NEGATIVE IMPACT
Summit Therapeutics fell 5.7% to $2.80 in pre-market trading after a 16% jump on Monday, following updated Phase II data for Ivonescimab presented at a healthcare conference.
The pre-market decline could be a correction following Monday's jump, as investors digest the new data presented.
CONFIDENCE 65
IMPORTANCE 65
RELEVANCE 60
POSITIVE IMPACT
Juniper Networks may be acquired by Hewlett Packard Enterprise, with the deal potentially valued at around $13 billion.
Juniper Networks' stock may see a short-term increase if the acquisition by HPE is confirmed, as buyouts typically offer a premium to current stock prices.
CONFIDENCE 75
IMPORTANCE 90
RELEVANCE 90